Skip to content
Women’s health has long been an underserved area when it comes to clinical innovation, R&D, and funding—the Women’s Health Innovation Opportunity Map (WHOM) is […]
Women’s Health Innovation Opportunity Map launches Read More »
Biotech was front and center as Biotechnology Innovation Organization (BIO) CEO Rachel King met with Maryland Governor Wes Moore at the University of Maryland
BIO CEO meets Maryland Governor to highlight state’s vital relationship with biotech Read More »
Led by the idea that medical treatments need to be simple and accessible, Dr. Ted Love became President and CEO of Global Blood Therapeutics
Can sickle cell disease become a thing of the past? Dr. Love believes it can. Read More »
“The biotech sisterhood is the antidote to the pharma bros,” said Angie You, Ph.D., Chief Executive Officer at Architect Therapeutics, during a lively conversation
Meet the biotech sisterhood—women supporting women in the pharma sector Read More »
Drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, according to Sept. 20 testimony in Congress from John
BIO Vice Chair John F. Crowley to Congress: IRA reduces access to innovative drugs Read More »
We need to make progress against the next pandemic, Phyllis Arthur, Senior Vice President of Infectious Diseases & Emerging Science Policy at the Biotechnology
Plan now for next pandemic, BIO’s Phyllis Arthur tells UN preparedness panel Read More »
The BIO Investor Forum 2023, hosted by the Biotechnology Innovation Organization (BIO), is right around the corner. Returning to San Francisco on October 17-18,
Why attend the BIO Investor Forum 2023? An investor and a company explain. Read More »
Horseshoe crabs have been living in the ocean for almost half a billion years, surviving five mass extinctions. However, their use in lab tests
Drug makers promote new toxin testing technology to spare horseshoe crabs Read More »
September is a perfect time to schedule your flu vaccine– as well as COVID and, if you’re eligible, the new RSV vaccines. And with
What you need to know about the upcoming flu season Read More »
The Biotechnology Innovation Organization (BIO) filed an amicus brief opposing the Federal Trade Commission (FTC) lawsuit to block Amgen’s acquisition of Horizon, arguing that
BIO to file amicus brief opposing FTC interference in vital biotech merger activity Read More »
